Although healthcare mergers and acquisition (M&A) activity declined in the wake of COVID-19, experts predict a rebound is imminent. How might this slowdown highlight the need for greater “scale, coordination, and innovation” in the industry?
Although healthcare mergers and acquisition (M&A) activity declined in the wake of COVID-19, experts predict a rebound is imminent. How might this slowdown highlight the need for greater “scale, coordination, and innovation” in the industry?